McKenzie Brown1, Sean Nassoiy1, Whitney Chaney1, Timothy P Plackett1, Robert H Blackwell2, Fred Luchette3, Milo Engoren4, Joseph Posluszny5. 1. Department of Surgery and Public Health Sciences, Loyola University Medical Center, Maywood, Illinois. 2. Department of Surgery and Public Health Sciences, Loyola University Medical Center, Maywood, Illinois; Department of Urology, Loyola University Medical Center, Maywood, Illinois. 3. Department of Surgery and Public Health Sciences, Loyola University Medical Center, Maywood, Illinois; Department of Surgery, Edward Hines Jr. Veterans Administration Hospital, Maywood, Illinois. 4. Department of Anesthesiology, University of Michigan Medical Center, Ann Arbor, Michigan. 5. Department of Surgery and Public Health Sciences, Loyola University Medical Center, Maywood, Illinois; Department of Surgery, Edward Hines Jr. Veterans Administration Hospital, Maywood, Illinois. Electronic address: joseph.posluszny@nm.org.
Abstract
BACKGROUND: Atrial fibrillation (AF) with rapid ventricular rate (RVR; heart rate >100) in noncardiac postoperative surgical patients is associated with poor outcomes. The objective of this study was to evaluate the practice patterns of AF management in a surgical intensive care unit to determine practices associated with rate and rhythm control and additional outcomes. MATERIALS AND METHODS: Adult patients (≥18 y) admitted to the surgical intensive care unit (SICU) from June 2014 to June 2015 were retrospectively screened for the development of new-onset AF with RVR. Demographics, hospital course, evaluation and treatment of AF with RVR, and outcome were evaluated and analyzed. RESULTS: Thousand seventy patients were admitted to the SICU during the study period; 33 met inclusion criteria (3.1%). Twenty-six patients (79%) had rate and rhythm control within 48 h of AF with RVR onset. β-Blockers were the most commonly used initial medication (67%) but were successful at rate and rhythm control in only 27% of patients (6/22). Amiodarone had the highest rate of success if used initially (5/6, 83%) and secondarily (11/13, 85%). Failure to control rate and rhythm was associated with a greater likelihood of comorbidities (100% versus 57%; P = 0.06). CONCLUSIONS: New-onset AF with RVR in the noncardiac postoperative patient is associated with a high mortality (21%). Amiodarone is the most effective treatment for rate and rhythm control. Failure to establish rate and rhythm control was associated with cardiac comorbidities. These results will help to form future algorithms for the treatment of AF with RVR in the SICU.
BACKGROUND:Atrial fibrillation (AF) with rapid ventricular rate (RVR; heart rate >100) in noncardiac postoperative surgical patients is associated with poor outcomes. The objective of this study was to evaluate the practice patterns of AF management in a surgical intensive care unit to determine practices associated with rate and rhythm control and additional outcomes. MATERIALS AND METHODS: Adult patients (≥18 y) admitted to the surgical intensive care unit (SICU) from June 2014 to June 2015 were retrospectively screened for the development of new-onset AF with RVR. Demographics, hospital course, evaluation and treatment of AF with RVR, and outcome were evaluated and analyzed. RESULTS: Thousand seventy patients were admitted to the SICU during the study period; 33 met inclusion criteria (3.1%). Twenty-six patients (79%) had rate and rhythm control within 48 h of AF with RVR onset. β-Blockers were the most commonly used initial medication (67%) but were successful at rate and rhythm control in only 27% of patients (6/22). Amiodarone had the highest rate of success if used initially (5/6, 83%) and secondarily (11/13, 85%). Failure to control rate and rhythm was associated with a greater likelihood of comorbidities (100% versus 57%; P = 0.06). CONCLUSIONS: New-onset AF with RVR in the noncardiac postoperative patient is associated with a high mortality (21%). Amiodarone is the most effective treatment for rate and rhythm control. Failure to establish rate and rhythm control was associated with cardiac comorbidities. These results will help to form future algorithms for the treatment of AF with RVR in the SICU.
Authors: Ciara M Shaver; Wei Chen; David R Janz; Addison K May; Dawood Darbar; Gordon R Bernard; Julie A Bastarache; Lorraine B Ware Journal: Crit Care Med Date: 2015-10 Impact factor: 7.598
Authors: Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy Journal: J Am Coll Cardiol Date: 2014-03-28 Impact factor: 24.094
Authors: Nalin Chokengarmwong; Daniel Dante Yeh; Yuchiao Chang; Luis Alfonso Ortiz; Haytham M A Kaafarani; Peter Fagenholz; David R King; Marc DeMoya; Kathryn Butler; Jarone Lee; George Velmahos; James Louis Januzzi; Elizabeth Lee-Lewandrowski; Kent Lewandrowski Journal: J Trauma Acute Care Surg Date: 2017-09 Impact factor: 3.313
Authors: Orla Mc Cormack; Alex Zaborowski; Sinead King; Laura Healy; Caroline Daly; Naoimh OʼFarrell; Claire L Donohoe; Narayanasamy Ravi; John V Reynolds Journal: Ann Surg Date: 2014-11 Impact factor: 12.969
Authors: P J Devereaux; Homer Yang; Salim Yusuf; Gordon Guyatt; Kate Leslie; Juan Carlos Villar; Denis Xavier; Susan Chrolavicius; Launi Greenspan; Janice Pogue; Prem Pais; Lisheng Liu; Shouchun Xu; German Málaga; Alvaro Avezum; Matthew Chan; Victor M Montori; Mike Jacka; Peter Choi Journal: Lancet Date: 2008-05-12 Impact factor: 79.321
Authors: Philippe Seguin; Thomas Signouret; Bruno Laviolle; Bernard Branger; Yannick Mallédant Journal: Crit Care Med Date: 2004-03 Impact factor: 7.598
Authors: Mik Wetterslev; Nicolai Haase; Christian Hassager; Emilie P Belley-Cote; William F McIntyre; Youzhong An; Jiawei Shen; Alexandre Biasi Cavalcanti; Fernando G Zampieri; Helio Penna Guimaraes; Anders Granholm; Anders Perner; Morten Hylander Møller Journal: Intensive Care Med Date: 2019-05-14 Impact factor: 17.440
Authors: Laura Drikite; Jonathan P Bedford; Liam O'Bryan; Tatjana Petrinic; Kim Rajappan; James Doidge; David A Harrison; Kathryn M Rowan; Paul R Mouncey; Duncan Young; Peter J Watkinson; Mark Corbett Journal: Crit Care Date: 2021-07-21 Impact factor: 9.097
Authors: Liam Joseph O'Bryan; Oliver C Redfern; Jonathan Bedford; Tatjana Petrinic; J Duncan Young; Peter J Watkinson Journal: BMJ Open Date: 2020-03-24 Impact factor: 2.692